Cross Country Healthcare faces a challenging transition as it navigates a post-pandemic market contraction, evidenced by a 17.8% year-over-year revenue decline in 2026Q1.
Price trend, volume and key moving averages
Trailing total returns as of 11/7/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q2 2026Latest May 7, 2026 | -$0.03+40.0% vs -$0.05 | $241M+1.7% vs $237M |
Q2 2026 Mar 4, 2026 | -$0.06-300.0% vs $0.03 | $237M-6.9% vs $254M |
Q4 2025 Nov 12, 2025 | $0.03-25.0% vs $0.04 | $250M-1.7% vs $254M |
Q3 2025 Aug 6, 2025 | -$0.01-114.3% vs $0.07 | $274M-6.7% vs $294M |
Benchmark CCRN against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Cross Country Healthcare, Inc. (CCRN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $13.25 | $428.06M | -4.52 | -21.56% | -9% | -25.57% | — | |
| $36.19 | $1.4B | -14.59 | -8.49% | 3.06% | 15.31% | — | |
| $12.15 | $369.41M | -7.55 | 3.1% | -3.35% | -20.78% | — | |
| $24.28 | $1.67B | 29.98 | 7.08% | 5.58% | 20.22% | — | |
| $13.82 | $478.95M | -1.91 | -1.87% | -6.73% | -27.06% | 2.27% | |
| $44.50 | $2.07B | -153.45 | 0.58% | 0.64% | 5.75% | 3.22% |
Cross Country Healthcare, Inc. (CCRN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Cross Country Healthcare, Inc. (CCRN) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 28, 2026·SEC
Jul 17, 2026·SEC
Jul 6, 2026·SEC
Get notified when CCRN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Cross Country Healthcare, Inc. (CCRN) stock FAQ — growth, dividends, profitability & financials explained
Cross Country Healthcare, Inc. (CCRN) reported $1.00B in revenue over the trailing twelve months. Revenue was $1.05B in fiscal year 2025. That is 444% more than the $193.8M of fiscal year 1999.
Cross Country Healthcare, Inc. (CCRN) revenue fell by 21.6% in fiscal year 2025, compared with the prior fiscal year.
No. Cross Country Healthcare, Inc. (CCRN) reported a net loss of $98.6M over the trailing twelve months.
Cross Country Healthcare, Inc. (CCRN) had a return on equity (ROE) of -25.6% in fiscal year 2025. A negative ROE means the company lost money over the period.
Cross Country Healthcare, Inc. (CCRN) generated $39.6M in free cash flow over the trailing twelve months.
